Opposite effects of thrombospondin-1 via CD36 and CD47 on homotypic aggregation of monocytic cells

Matrix Biology

Volumn 21, Issue 5, 2002, Pages 441-448

  Yamauchi, Yasushi ^a   Kuroki, Motomu ^a   Imakiire, Takayuki ^a   Uno, Koichi ^a   Abe, Hironori ^a   Beppu, Richiko ^a   Yamashita, Yuichi ^a   Kuroki, Masahide ^a   Shirakusa, Takayuki ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aggregation; CD36; CD47; LFA 1; Thrombospondin 1; U937

Indexed keywords

CD36 ANTIGEN; CD47 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P70; THROMBOSPONDIN 1;

ARTICLE; BINDING SITE; CELL AGGREGATION; CELL STRAIN U937; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANTIGENS, CD; ANTIGENS, CD36; ANTIGENS, CD47; CARRIER PROTEINS; CELL AGGREGATION; CELL LINE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MOLECULAR WEIGHT; MONOCYTES; PEPTIDE FRAGMENTS; THROMBOSPONDIN 1;

EID: 0036702030     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(02)00036-7     Document Type: Article

References (34)

1. Anonick P.K., Yoo J.K., Webb D.J., Gonias S.L. Characterization of the antiplasmin activity of human thrombospondin-1 in solution. Biochem. J. 289:1993;903-909.
2. Armant M., Avice M.N., Hermann P., et al. CD47 ligation selectively downregulates human interleukin 12 production. J. Exp. Med. 190:1999;1175-1182.
3. Asch A.S., Silbiger S., Heimer E., Nachman R.L. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem. Biophys. Res. Commun. 182:1992;1208-1217.
4. Benjamin S.W., Joseph I. Phosphatase inhibitors promote ICAM-1 and LFA-1 mediated homotypic aggregation of U937 cells. Biochem. Biophys. Res. Commun. 226:1996;82-87.
5. Beppu R., Nakamura K., Miyajima-Uchida H., et al. Soluble thrombospondin-1 suppresses T cell proliferation and enhances IL-10 secretion by antigen presenting cells stimulated with phytohemagglutinin. Immunol. Invest. 30:2001;143-156.
6. Demeure C.E., Tanaka H., Mateo V., Rubio M., Delespesse G., Sarfati M. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J. Immunol. 164:2000;2193-2199.
7. Frostegard J., Nilsson J., Haegerstrand A., Hamsten A., Wigzell H., Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc. Natl. Acad. Sci. USA. 87:1990;904-908.
8. Gao A.G., Lindberg F.P., Finn M.B., Blystone S.D., Brown E.J., Frazier W.A. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271:1996;21-24.
9. Greenwood J.A., Pallero M.A., Theibert A.B., Murphy-Ullrich J.E. Thrombospondin signaling of focal adhesion disassembly requires activation of phosphoinositide 3-kinase. J. Biol. Chem. 273:1998;1755-1763.
10. Hillery C.A., Scott J.P., Du M.C. The carboxy-terminal cell-binding domain of thrombospondin is essential for sickle red blood cell adhesion. Blood. 94:1999;302-309.
11. Hmama Z., Knutson K.L., Herrera-Velit P., Nandan D., Reiner N.E. Monocyte adherence induced by lipopolysaccharide involves CD14, LFA-1, and cytohesin-1. Regulation by Rho and phosphatidylinositol 3-kinase. J. Biol. Chem. 274:1999;1050-1057.
12. Ikewaki N., Yamada A., Sonoda A., Inoko H. A novel monoclonal antibody mNI-58A against the alpha-chain of leukocyte function-associated antigen-1 (LFA-1) blocks the homotypic cell aggregation and actively regulates morphological changes in the phorbol myristate acetate (PMA)-activated human monocyte-like cell line, U937. Tissue Antigens. 48:1996;161-173.
13. Jaffe E.A., Ruggiero J.T., Falcone D.J. Monocytes and macrophages synthesize and secrete thrombospondin. Blood. 65:1985;79-84.
14. Janabi M., Yamashita S., Hirano K., et al. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler. Thromb. Vasc. Biol. 20:2000;1953-1960.
15. Kasinrerk W., Tokrasinwit N., Phunpae P. CD147 monoclonal antibodies induce homotypic cell aggregation of monocytic cell line U937 via LFA-1/ICAM-1 pathway. Immunology. 96:1999;184-192.
16. Lastres P., Almendro N., Bellon T., Lopez-Guerrero J.A., Eritja R., Bernabeu C. Functional regulation of platelet/endothelial cell adhesion molecule-1 by TGF-beta 1 in promonocytic U-937 cells. J. Immunol. 153:1994;4206-4218.
17. Leung L.L. Role of thrombospondin in platelet aggregation. J. Clin. Invest. 74:1984;1764-1772.
18. Mazerolles F., Barbat C., Hivroz C., Fischer A. Phosphatidylinositol 3-kinase participates in p56(lck)/CD4-dependent down-regulation of LFA-1-mediated T cell adhesion. J. Immunol. 157:1996;4844-4854.
19. Mosher D.F., Doyle M.J., Jaffe E.A. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J. Cell Biol. 93:1982;343-348.
20. Murphy-Ullrich J.E., Schultz-Cherry S., Hook M. Transforming growth factor-beta complexes with thrombospondin. Mol. Biol. Cell. 3:1992;181-188.
21. Rabhi-Sabile S., Pidard D., Lawler J., Renesto P., Chignard M., Legrand C. Proteolysis of thrombospondin during cathepsin-G-induced platelet aggregation: functional role of the 165-kDa carboxy-terminal fragment. FEBS Lett. 386:1996;82-86.
22. Savill J., Hogg N., Ren Y., Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1992;1513-1522.
23. Schultz-Cherry S., Chen H., Mosher D.F., et al. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J. Biol. Chem. 270:1995;7304-7310.
24. Silverstein R.L., Asch A.S., Nachman R.L. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J. Clin. Invest. 84:1989;546-552.
25. Silverstein R.L., Baird M., Lo S.K., Yesner L.M. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. J. Biol. Chem. 267:1992;16607-16612.
26. Sipes J.M., Krutzsch H.C., Lawler J., Roberts D.D. Cooperation between thrombospondin-1 type 1 repeat peptides and alpha(v)beta(3) integrin ligands to promote melanoma cell spreading and focal adhesion kinase phosphorylation. J. Biol. Chem. 274:1999;22755-22762.
27. Sundstrom C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. 17:1976;565-577.
28. Taipale J., Matikainen S., Hurme M., Keski-Oja J. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation. Cell Growth Diff. 5:1994;1309-1319.
29. Taraboletti G., Roberts D., Liotta L.A., Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111:1990;765-772.
30. Tolsma S.S., Volpert O.V., Good D.J., Frazier W.A., Polverini P.J., Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122:1993;497-511.
31. Tuszynski G.P., Srivastava S., Switalska H.I., Holt J.C., Cierniewski C.S., Niewiarowski S. The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction. J. Biol. Chem. 260:1985;12240-12245.
32. Watanabe T., Fan J. Atherosclerosis and inflammation mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis. Int. J. Cardiol. 66:1998;45-53.
33. Yamashita Y., Kurohiji T., Tuszynski G.P., Sakai T., Shirakusa T. Plasma thrombospondin levels in patients with colorectal carcinoma. Cancer. 82:1998;632-638.
34. Yesner L.M., Huh H.Y., Pearce S.F., Silverstein R.L. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 16:1996;1019-1025.